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1. Introduction 
The function of immunoglobulin E (IgE) as media- 
tor of allergic reactions of the immediate type is ex- 
plained by its specific interaction both with a particu- 
lar antigen (allergen) and with receptors on basophilic 
leucocytes and mast cells [l] . The cytotropic property 
of the IgE molecule is a characteristic of the Fc region 
[2, 3] and in a previous paper the amino acid sequence 
of the C-terminal domain was reported [4 J . In the pre- 
sent paper we report the primary structure of the se- 
cond last domain (C,3) in Fc which appears to be 
homologous to the C+2 AND C,3 domains. 
2. Materials and methods 
IgE myeloma protein was isolated from the serum 
of patient ND by salting-out (Na,SO,) and further 
purified by ion-exchange chromatography and gel fil- 
tration as previously described [ I] . 
For partial reduction-14C-alkylation 2.45 pmoles 
of lyophilized IgE was dissolved in 0.3 M Tris-HCl-2 
mM EDTA Na, pH 7.6 (protein concn. 30 mg/ml) 
and incubated for 30 min at 37°C with N, -bubbling 
prior to the addition of 0.3 mmoles of DTT (dithio- 
threitol, Sigma). After 60 min the reduced protein 
was alkylated with 0.3 mmoles of 14C-labelled-iodo- 
acetate (specific activity 0.2 mCi/mM) for 45 min at 
0°C (icebath) and finally fractionated on Sephadex 
G-150 (3.2 X 180 cm) in 5% formic acid. Fractions 
containing epsilon chain were lyophilized (yield 4.6 
pmoles) and reduced with DTT (10 mM) in 6 M 
guanidine HCI-0.3 M Tris-HCI pH 7.6 (protein con- 
centration 10 mg/ml) for 120 min at 37°C. 
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One portion (A) containing about 2.3 pmoles of 
the completely reduced epsilon chain was alkylated 
with ‘cold’ iodoacetate, another portion (B) was 
alkylated with 14C-labelled iodoacetate (specific ac- 
tivity 0.2 mCi/mM) for 60 min at O”C, dialyzed against 
1% sodium chloride and 0.05% acetic acid and finally 
lyophilized. For cyanogen bromide cleavage the lyo- 
philized preparations A and B (about 2.3 Imole each) 
of completely reduced and alkulated epsilon chain 
were dissolved in 70% formic acid and cyanogen bro- 
mide (Fluka) added to give a CNBr:protein ratio (w/w) 
of 1: 1. After 18 hr at 25°C the two solutions were 
diluted four times with water and lyophilized. The 
products were dissolved in 5% formic acid and frac- 
tionated on Sephadex G-100 in the same solvent. Six 
peaks were obtained; fractions under peak III 
(Fe/V, = 0.54) were pooled concentrated by lyophih- 
zation and the product further purified on Sephadex 
G-50 in 5% formic acid. One major peak (Fe/T/; = 0.41) 
was obtained, which consisted of a single component 
as revealed by starch gel electrophoresis in acid urea 
[5] . The fragment (designated A:111 and B:III respec- 
tively) yielded about 18% of the amount of epsilon 
chain subjected to CNBr-cleavage. Tryptic cleavage of 
fragment A:111 and B:III was done in 1% NH,CO, for 
abour 4 hr at 37°C using an enzyme:substrate ratio of 
1: 100. Chymotryptic cleavage of fragment A:111 was 
done in 1% NH4C03 for about 6 hr at 37°C using an 
enzyme:substrate ratio of 1: 100. Peptic cleavage of 
fragment B:III was done in 0.01 M HCl for 18 hr at 
25°C using an enzyme:substrate ratio of 1:50. The 
digests (10 mg) were fractionated by paper electro- 
phoresis at pH 6.5 followed by purification of the 
peptides by paper chromatography in butanol-acetic 
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Fig. 1. The amino acid sequence of fragment III. Tryptic(T), chymotryptic(C) and peptic(P) peptides were subjected to the 
dansyl-Edman procedure as indicated by arrows. Double arrows indicate that the residue was obtained as a free amino acid at the 
end of the degradation; the C-terminus of TN5 was determined after cleavage with carboxypeptidase B. An Asx within a box in- 
dicates the site of attachment of an oligosaccharade side chain. 
acid-water-pyridine (15:3: 12: 10) and paper electro- 
phoresis at pH 3.5. The peptides were analyzed and 
then subjected to the dansyl-Edman procedure as 
described previously [6, 7 j . Carbohydrate analysis 
was done by GLC on TMS derivatives of methyl 
pyranosides as previously described [Sl . For selective 
carboxymethylation of methionyl residues [9j 0.18 
pmoles of IgE were dissolved in 4.5 ml of 5% formic 
acid, alkylated with 168 pmoles of 14C-labelled iodo- 
acetate (specific activity 0.3 mCi/mM) for 50 hr at 
37°C. After dialysis against 1% NH,CO, the product 
was subjected to tryptic cleavage for 5 hr at 37°C 
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Table 1 
Comparison of the carbohydrate composition and ammo acid sequence of the glycopeptide regions of CH3 from human IgE (ND) 
and IgM (Ou) * 
__.____ 
Residues per molecule 
Fucose Mannose Galactose N-Acetyl N-acetyl 
glucosamine neuraminic acid 
CHO-l** Ce3 (ND) -Gly-Thr-Val-Asn-Leu-Thr-Trp- 1 3 2 3 l-2 
$3 (Ou) -Th-His-Thr-As?-IIe-Ser-Gh- 1 3 2 4-5 ? 
CHO-2 Ce3 (ND) -Lys-Gln-Arg-Asn-Gly-Thr-Leu- - 6 _ 2 - 
c,3 (Ou) -Ser-His-Pro-Asn-Ala-Thr-Phe- - 5 _ 2 - 
*Taken from ref. [ 111. 
** As shown in fig. 3, the side chains are attached to asparaginyl residues at non-homologous positions. 
using an enzyme:substrate ratio of 1: 100 and the 
digest fractionated as described above. Radioactive 
peptides were identified by autoradiography for 24 hr 
using Kodak RP 14 Xomat. 
3. Results and discussion 
Cyanogen bromide cleavage of completely reduced 
and alkylated epsiolon chain ND yields at least six 
fragments, of which only two (peak I and peak III), 
Sephadex G-100) were found to contain [14C] carboxy- 
methylated sulphydryl groups presumably derived 
from both inter- and intrachain disulphide bonds. 
Fragment III was selected for the present study since 
it represents a carbohydrate containing portion of the 
Fc region (H. Bennich, unpublished results), which 
might carry the D2-antigenic characteristics of IgE [ I] 
and furthermore be located adjacent to the previously 
sequenced C-terminal domain of the epsilon chain [4] _ 
Fig. 1. shows the tentative amino acid sequence of 
fragment III as deduced from the results of dansyl- 
Edman degradation of overlapping peptides produced 
by enzymic cleavage. 
The amino acid composition derived from the se- 
quence is in close agreement with the composition 
found by amino acid analysis of a hydrolysate of the 
intact fragment, except for the values of alanine, gly- 
tine and proline, which exceed the expected numbers 
by one residue each. Although this discrepancy would 
indicate the possibility that a tri-peptide or a single re- 
sidue has escaped our attention, the consistent com- 
positions and sequence data of the many individual 
peptides speak in favour of a correct sequence of frag- 
ment III. 
Fragment III contains 10 arginyl and 8 lysyl-resi- 
dues, but only 14 tryptic peptides could be isolated. 
The sequence contains one -Lys-Lys- and two 
-Arg-Lys- bonds and tryptic cleavage yielded in 
addition to free lysine two arginine-peptides (TN5 
and TNlB) having an aminoterminal lysyl-residue. In 
one of the tryptic peptides(TB2A) the presence of 
both arginine and lysine was explained by the resis- 
tance of a Lys-Pro bond to enzymic attack. Two of 
the tryptic peptides (TN8 and ITN2B) did not con- 
tain arginine, lysine or homoserine/homoserine lactone 
thus indicating the presence of an active ‘contaminant’ 
in the trypsin preparation. As shown in fig. 1 the tryp- 
tic peptides TA2 and TN3, containing 27 and 18 
amino acid residues respectively, were too large for 
complete degradation by the manual Edman procedure 
and thus required further cleavage by chymotrypsin 
and/or pepsin. One tryptic peptide having a prolyl 
residue in the aminoterminal position and located be- 
tween TN8 and TN5 (fig. 1) was not isolated, 
Concerning the location of fragment III within the 
epsilon chain, the isolation of a radiolabelled peptide 
(Ala-Leu-Met-Arg) from a tryptic digest of IgE (ND) 
selectively carboxymethylated at the methionyl-resi- 
dues favoured the assumption that the carboxyter- 
minus(Met) of fragment III could be linked to the 
aminoterminus(Arg) of the previously characterized 
CNBr-fragment e4 [4] _ Fragment III contains 4 half- 
cystinyl residues. After partial reduction, only one of 
the half-cystines could be [ 14C j carboxymethylated, 
which indicates that it participates in the formation 
of an inter-chain disulphide bridge. After complete 
reduction, the remaining half-cystines could be radio- 
labelled; at present we assume that the two half- 
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Fig. 2. Comparison of the sequence of fragment III with the sequence of the Cy2-domain [ 13,141 and the C 3domain [ 11,161. 
The location of an oligosaccharide unit is indicated by CHO. Gaps introduced to maximaze homology are m lcated by a horizontal .J 
bar. 
cystinyl residues located in the carboxyterminal half 
of fragment III form a disulphide loop within the 
fragment, while the first half-cystinyl residue in the 
aminoterminal half participates in a disulphide loop 
located within the previously postulated extra domain 
of the epsilon chain [lo] . 
Two oligosaccharide side chains are present in frag- 
ment III. Table 1 shows that they differ as regards 
constituent monosaccharides. Both side chains are 
located within the postulated disulphide loop of 
fragment III and presumably attached to the poly- 
peptide chain by a GlcNAc-Asn linkage. The pre- 
sence of two oligosaccharide units, one having a com- 
plex and the other a simple structure, has been de- 
scribed to be a characteristic also of the C,-domain 
[l l] . The amino acid sequence of fragment III of the 
epsilon chain is in many respects very similar to the 
sequences of the C,2- and C,3-domains (fig. 2), but 
the degree of homology is significantly lower than 
that found for the C-terminal domains of the E-, y- 
and p-chains [4]. 
The skin-faing properties of the IgE molecule have 
60 
been localized to the portion of the epsilon chain com- 
prising the C,3- and C,4-domains [IO], but it is not 
known at present, whether the binding site(s) is form- 
ed by a cis or a trulzs-domain interaction or is an in- 
trinsic property of one or the other domain. However, 
the strikingly high degree of homology between the 
C,4 and C,3 (fig. 3) might be of particular significance 
in view of that C, seems to be the domain responsible 
for the cytotropic activity of human IgG [ 121. 
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CNBr 
fragment III 
CNBr CNBr 
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Fig. 3. Comparison of analogous domains and inter-domain regions of the epsilon (fig. 2 and ref. [4]), gamma [ 13, 141, mu [ 11, 
161 and alpha [ 151 polypeptide chains. Figures indicate the degree of homology (in per cent and, within brackets, the minimum 
number of base changes required to convert one sequence into the other; gaps are computed as two base changes. 
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